Re: Zenith got a licensing upgrade.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10734 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Zenith got a licensing upgrade.

in response to

Zenith got a licensing upgrade.

rocketman2

posted on Nov 15, 2021 02:51PM

Perhaps Zenith can pay out what is owed to Resverlogix in the amount of $872K US, in accordance with Sept 30, 2021 Financials.